Thank you for choosing AMRI for your drug discovery, development and manufacturing needs.
We are committed to providing exemplary customer service and strive to ensure that the best performance and results are delivered at all our sites around the world.
You can access the terms and conditions of our global services and solutions by clicking on the applicable link under the appropriate heading below.
**Please be informed that AMRI reserves the right, from time to time, in AMRI’s sole discretion, to amend its terms and conditions. Notice of any such changes is displayed alongside the applicable heading below. Please note that such changes shall be binding on all agreements dated on or after the date on which such changes become effective. It is your responsibility to review and familiarize yourself with the terms and conditions governing your agreement, and it is recommended that you print and retain a copy of such terms and conditions for your records.**
For Purchases and Sales from AMRI’s Fine Chemical Catalogue (“Catalogue”)
For Drug Discovery, Chemical Development and Analytical Services (“DDS”) (*Change in Terms Effective 8/25/2017*)
- for agreements dated on or after 8/25/2017
- for agreements dated before 8/25/2017
- AMRI and/or its affiliates (with respect to discovery and development services)
- Albany Molecular Research Hyderabad Research Centre, Pvt. Ltd., AMRI India Pvt. Ltd. and/or Finekem
- Albany Molecular Research (UK) Ltd.
For the Manufacturing and Supply of Active Pharmaceutical Ingredients, Intermediates and/or Fine Chemicals (“API”) (*Change in Terms Effective 8/25/2017*)
- for agreements dated on or after 8/25/2017
- for agreements dated before 8/25/2017
For the Development, Manufacturing and Supply of Drug Products (“DP”)
- AMRI Burlington, Inc.
- Albany Molecular Research (Glasgow) Limited
- OsoBio Biopharmaceuticals Manufacturing, LLC
For additional information or to contact a customer service representative, please email: Customerservice@amriglobal.com